C-M Charlie Ma, PhD, Named Vice Chairman of Radiation Oncology at Fox Chase
Philadelphia (June 15, 2009) – Fox Chase Cancer Center has promoted C-M Charlie Ma, PhD, to vice chairman of the department of radiation oncology. Ma, a resident of Huntingdon Valley, Pa., joined the staff at Fox Chase in 2001 and is currently the director of radiation physics at Fox Chase.
Ma is an internationally recognized expert in the physics of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT). Under his leadership, the medical physics division of the department of radiation oncology at Fox Chase has developed into one of the premier groups in North America.
“Dr. Ma has been instrumental in strengthening our mission through the continued collaboration between the research and clinical staffs,” noted Eric M. Horwitz, MD, acting chairman of the department of radiation oncology. “As Fox Chase Cancer Center and the department of radiation oncology grow on the main campus and beyond, I look forward to Dr. Ma’s continued leadership and expertise.”
At Fox Chase, Ma has lead a research team focused on laser accelerated proton beams for radiation therapy, along with clinical research and developments for advanced radiotherapy treatments. His research interests include multi-leaf collimators, leaf-sequencing algorithms and IMRT beam delivery and quality assurance, energy- and intensity-modulated electron therapy, and Monte Carlo tools for IMRT.
Ma earned his PhD and completed his post-doctorate fellowship in medical physics (radiotherapy) at The Institute of Cancer Research, a college of the University of London that works in partnership with The Royal Marsden NHS Foundation Trust, in the United Kingdom. He received his M.S. in precision instruments at East China University of Technology in Shanghai, China. Ma did his undergraduate training in laser instruments at Zhejiang University in Hangzhou, China.
In addition, Ma is an active member of the American Association of Physicists in Medicine, American College of Medical Physics, American Society for Therapeutic Radiology and Oncology, European Society for Therapeutic Radiology and Oncology, and the Canadian Organization of Medical Physicists.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Diana Quattrone at 215-728-7784.